Boston Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28M | Buy |
|
|||||
|
2025
Q2 | $40.7M | Buy |
|
|||||
|
2025
Q1 | $33.4M | Sell |
|
|||||
|
2024
Q4 | $41.5M | Buy |
|
|||||
|
2024
Q3 | $33.5M | Sell |
|
|||||
|
2024
Q2 | $35.7M | Sell |
|
|||||
|
2024
Q1 | $38.3M | Sell |
|
|||||
|
2023
Q4 | $60.4M | Sell |
|
|||||
|
2023
Q3 | $65.1M | Sell |
|
|||||
|
2023
Q2 | $65.1M | Buy |
|
|||||
|
2023
Q1 | $54.9M | Buy |
|
|||||
|
2022
Q4 | $41M | Buy |
|
|||||
|
2022
Q3 | $22.6M | Sell |
|
|||||
|
2022
Q2 | $20.3M | Buy |
|
|||||
|
2022
Q1 | $19.1M | Buy |
|
|||||
|
2021
Q4 | $15.9M | Sell |
|
|||||
|
2021
Q3 | $21.5M | Sell |
|
|||||
|
2021
Q2 | $20.4M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $1.79M | Buy |
|